US buys 200M more COVID-19 vaccine doses from Pfizer

The U.S. purchased an additional 200 million doses of Pfizer’s COVID-19 vaccine, the drugmaker said July 23.

Advertisement

Pfizer expects to deliver 110 million doses by Dec. 31, with the remaining 90 million doses expected to be delivered by April 30.

The U.S. also has the option to obtain an updated version of the vaccine designed to target coronavirus variants, should one be authorized.

The deal brings the total number of Pfizer doses purchased by the U.S. government to 500 million.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.